Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model

An early identification of the tumor response to sorafenib treatment is indispensable for selecting optimal personalized treatment strategies. However, at present, no reliable predictors are clinically available. (18)F-fluorothymidine ((18)F-FLT) positron emission tomography (PET) is used to assess...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: MURAKAMI, MASAHIRO, ZHAO, SONGJI, ZHAO, YAN, YU, WENWEN, FATEMA, CHOWDHURY NUSRAT, NISHIJIMA, KEN-ICHI, YAMASAKI, MASAHIRO, TAKIGUCHI, MITSUYOSHI, TAMAKI, NAGARA, KUGE, YUJI
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2013
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789029/
https://ncbi.nlm.nih.gov/pubmed/24137387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1459
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires